Tampere University Hospital is a teaching hospital of Tampere University along Teiskontie at the Kauppi district in Tampere, Finland.

There are 1,000 beds in Tampere University Hospital.

During the past decade, Tampere University Hospital conducted 219 clinical trials. In the 10-year time frame, 219 clinical trials started and 39 clinical trials were completed, i.e. on average, 17.8% percent of trials that started reached the finish line to date. In the past 5 years, 102 clinical trials started and 22 clinical trials were completed. i.e. 21.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tampere University Hospital" #1 sponsor was "Tampere University Hospital" with 103 trials, followed by "Tampere University" with 14 trials sponsored, "Helsinki University Central Hospital" with 13 trials sponsored, "Pfizer" with 13 trials sponsored and "Turku University Hospital" with 13 trials sponsored. Other sponsors include 179 different institutions and companies that sponsored additional 114 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tampere University Hospital" #1 collaborator was "Tampere University Hospital" with 38 trials as a collaborator, "Turku University Hospital" with 30 trials as a collaborator, "Helsinki University Central Hospital" with 28 trials as a collaborator, "Oulu University Hospital" with 27 trials as a collaborator and "Kuopio University Hospital" with 22 trials as a collaborator. Other collaborators include 381 different institutions and companies that were collaborators in the rest 232 trials.

According to Clinical.Site data, the most researched conditions in "Tampere University Hospital" are "Prostate Cancer" (21 trials), "Postoperative Pain" (6 trials), "Cancer" (5 trials), "Multiple Myeloma" (5 trials) and "Ovarian Cancer" (5 trials). Many other conditions were trialed in "Tampere University Hospital" in a lesser frequency.

Most popular intervention types in "Tampere University Hospital" are "Drug" (160 trials), "Procedure" (53 trials), "Other" (43 trials), "Device" (42 trials) and "Biological" (19 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (32 trials), "Bevacizumab" (5 trials), "Enzalutamide" (5 trials), "Conservative treatment" (4 trials) and "Degarelix" (4 trials). Other intervention names were less common.

The vast majority of trials in "Tampere University Hospital" are 272 trials for "All" genders, 35 trials for "Male" genders and 32 trials for "Female" genders.

Currently, there are 134 active trials in "Tampere University Hospital". 4 are not yet recruiting, 84 are recruiting, 44 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 145 completed trials in Tampere University Hospital, 3 suspended trials, and 21 terminated clinical trials to date.

Out of the total trials that were conducted in Tampere University Hospital, 20 "Phase 1" clinical trials were conducted, 56 "Phase 2" clinical trials and 75 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 37 trials, and there were also 95 trials that are defined as “Not Applicable".

Tampere University Hospital has several departments that took part in Clinical trials: "Tampere University Hospital Heart Center" - 13 trials, "Coxa, Hospital for Joint Replacement" - 7 trials, "Department of Urology-Tampere University Hospital-" - 6 trials, "Hatanpää Hospital" - 4 trials, "Tampere University Hospital; Hematology" - 4 trials, "Tampere University Hospital, Dept of Paediatrics" - 4 trials, "Tampere University Hospital, Paediatric Haematology and Oncology" - 2 trials, "Tampere University Hospital, Department of Plastic Surgery" - 2 trials, "Pirkanmaa Hospice" - 2 trials